en

PRODUCT DETAIL

Tizveni 100 mg koncentrát na infúzny roztok

Code 6266E
MA number EU/1/24/1797/002
Product Form: con inf 2(2x1)x10 ml/100 mg (liek.inj.skl.)
MA Status: E - Valid centralised marketing authorisation
Type of procedure: EU
Therapeutic Class: 44 - CYTOSTATICA
ATC:
L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
L01 ANTINEOPLASTIC AGENTS
L01F MONOCLONAL ANTIBODIES AND ANTIBODY DRUG CONJUGATES
L01FF PD-1/PDL-1 (Programmed cell death protein 1/death ligand 1) inhibitors
L01FF09 Tislelizumab
Shelf life: 36
Container: glass vial
Route of admin.: Intravenous use
Prescription Status: Medicinal product subject to restricted medical prescription.
Legal basis: Article 10a well-established use application
MA issued: 19.04.2024
Validity: 19.04.2029
SmPC + PL: European Medicines Agency's database
Safety feature Yes
Data update: 27.05.2024
eu-flag.png sk-flag.png